1111 related articles for article (PubMed ID: 26941017)
1. Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504.
Reddy MA; Das S; Zhuo C; Jin W; Wang M; Lanting L; Natarajan R
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):864-73. PubMed ID: 26941017
[TBL] [Abstract][Full Text] [Related]
2. Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice.
Reddy MA; Jin W; Villeneuve L; Wang M; Lanting L; Todorov I; Kato M; Natarajan R
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):721-9. PubMed ID: 22247255
[TBL] [Abstract][Full Text] [Related]
3. Coordinated augmentation of NFAT and NOD signaling mediates proliferative VSMC phenotype switch under hyperinsulinemia.
Shiny A; Regin B; Mohan V; Balasubramanyam M
Atherosclerosis; 2016 Mar; 246():257-66. PubMed ID: 26814423
[TBL] [Abstract][Full Text] [Related]
4. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of FOXO1/3 promotes vascular calcification.
Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype.
Vengrenyuk Y; Nishi H; Long X; Ouimet M; Savji N; Martinez FO; Cassella CP; Moore KJ; Ramsey SA; Miano JM; Fisher EA
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):535-46. PubMed ID: 25573853
[TBL] [Abstract][Full Text] [Related]
7. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
[TBL] [Abstract][Full Text] [Related]
9. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
10. MiR-135a Promotes Inflammatory Responses of Vascular Smooth Muscle Cells From db/db Mice via Downregulation of FOXO1.
Lu X; Yin D; Zhou B; Li T
Int Heart J; 2018 Jan; 59(1):170-179. PubMed ID: 29332916
[TBL] [Abstract][Full Text] [Related]
11. MiR-377-3p inhibits atherosclerosis-associated vascular smooth muscle cell proliferation and migration via targeting neuropilin2.
Wang H; Wei Z; Li H; Guan Y; Han Z; Wang H; Liu B
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32373927
[TBL] [Abstract][Full Text] [Related]
12. Flank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application.
Liu X; Cheng Y; Yang J; Qin S; Chen X; Tang X; Zhou X; Krall TJ; Zhang C
J Am Heart Assoc; 2013 Oct; 2(6):e000407. PubMed ID: 24166492
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-141 inhibits vascular smooth muscle cell proliferation through targeting PAPP-A.
Zhang Y; Chen B; Ming L; Qin H; Zheng L; Yue Z; Cheng Z; Wang Y; Zhang D; Liu C; Bin W; Hao Q; Song F; Ji B
Int J Clin Exp Pathol; 2015; 8(11):14401-8. PubMed ID: 26823756
[TBL] [Abstract][Full Text] [Related]
14. Msx2 is required for vascular smooth muscle cells osteoblastic differentiation but not calcification in insulin-resistant ob/ob mice.
Andrade MC; Carmo LS; Farias-Silva E; Liberman M
Atherosclerosis; 2017 Oct; 265():14-21. PubMed ID: 28829997
[TBL] [Abstract][Full Text] [Related]
15. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-124 controls human vascular smooth muscle cell phenotypic switch via Sp1.
Tang Y; Yu S; Liu Y; Zhang J; Han L; Xu Z
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H641-H649. PubMed ID: 28667053
[TBL] [Abstract][Full Text] [Related]
17. CircMAPK1 promotes the proliferation and migration of vascular smooth muscle cells through miR-22-3p/ methyl-CpG binding protein 2 axis.
Fu X; Niu T; Yang T; Li X
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2189-2198. PubMed ID: 34059381
[TBL] [Abstract][Full Text] [Related]
18. miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.
Yang F; Chen Q; He S; Yang M; Maguire EM; An W; Afzal TA; Luong LA; Zhang L; Xiao Q
Circulation; 2018 Apr; 137(17):1824-1841. PubMed ID: 29246895
[TBL] [Abstract][Full Text] [Related]
19. miRNA Regulation of the Hyperproliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes.
Torella D; Iaconetti C; Tarallo R; Marino F; Giurato G; Veneziano C; Aquila I; Scalise M; Mancuso T; Cianflone E; Valeriano C; Marotta P; Tammè L; Vicinanza C; Sasso FC; Cozzolino D; Torella M; Weisz A; Indolfi C
Diabetes; 2018 Dec; 67(12):2554-2568. PubMed ID: 30257973
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-221 and -222 in response to increased extracellular signal-regulated kinases 1/2 activity exacerbates neointimal hyperplasia in diabetes mellitus.
Lightell DJ; Moss SC; Woods TC
Atherosclerosis; 2018 Feb; 269():71-78. PubMed ID: 29276985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
